Trial Profile
An Open-Label, One-Arm, Multi-Site Trial of Precision Diagnosis Directing Histone Deacetylase Inhibitor Chidamide Target Total Therapy for Adult Early T-cell Progenitor Acute Lymphoblastic Leukemia/Lymphoma
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary) ; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Idarubicin; Mercaptopurine; Methotrexate; Pegaspargase; Vincristine
- Indications Precursor T-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology
- 20 Jun 2018 New trial record